Home > Result Summaries: Compounds > firategrast Result Summaries: firategrast GSKStudy ID Phase Title Summary (Download) 114107 phase 1 An open label, randomised healthy volunteer study to assess the single dose safety and pharmacokinetics of three modified release dosage forms of firategrast (0 citation(s)) 115517 phase 1 A single/repeat dose study with three oral formulations of Firategrast (immediate release tablet, modified release tablet, and naso-gastric infusion) in healthy male volunteers (0 citation(s)) A4M105038 phase 2 Randomised, Double-blind, Placebo-controlled, Parallel-group, Dose-ranging Study to Investigate the MRI Efficacy and the Safety of Six Months Administration of SB-683699 in Subjects with Relapsing-Remitting Multiple Sclerosis (0 citation(s)) A4M108119 phase 2 An open-label study of leukocyte counts in the cerebrospinal fluid and blood of subjects with relapsing forms of multiple sclerosis following treatment with firategrast (0 citation(s))
